Soleus Capital Master Fund, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for UROGEN PHARMA LTD. Ordinary Shares, par value NIS 0.01 per share (URGN)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
UROGEN PHARMA LTD. Ordinary Shares, par value NIS 0.01 per share
Symbol
URGN
Shares outstanding
46.5M shares
Disclosed Ownership
2.19M shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
05 Aug 2025, 17:00:03 UTC
Date of event
30 Jun 2025
Previous filing
16 Jun 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 4.7% 2.19M 0 2.19M /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 4.7% 2.19M 0 2.19M /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 4.7% 2.19M 0 2.19M /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 4.7% 2.19M 0 2.19M /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 4.7% 2.19M 0 2.19M /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 4.7% 2.19M 0 2.19M /s/ Guy Levy Guy Levy/Individual